NCT00930228View on ClinicalTrials.gov

Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2024

Study Completion Date

August 31, 2024

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Flutamide

Flutamide, 250 mg capsule for oral administration, twice a day for 4 weeks (or menstrual cycle length in normally-cycling controls)

DRUG

Placebo

Placebo, for oral administration, twice a day for 4 weeks (or menstrual cycle length in normally-cycling controls)

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT00930228 - Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter